# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-24-000017
Filing Date
2024-08-08
Accepted
2024-08-08 16:35:47
Documents
99
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tmb-20240630x10q.htm iXBRL | 10-Q | 2885918
2 | EX-10.1 | tmb-20240630xex10d1.htm | EX-10.1 | 454731
3 | EX-10.2 | tmb-20240630xex10d2.htm | EX-10.2 | 77410
4 | EX-31.1 | tmb-20240630xex31d1.htm | EX-31.1 | 10920
5 | EX-31.2 | tmb-20240630xex31d2.htm | EX-31.2 | 10731
6 | EX-32.1 | tmb-20240630xex32d1.htm | EX-32.1 | 5936
7 | EX-32.2 | tmb-20240630xex32d2.htm | EX-32.2 | 6131
8 | GRAPHIC | tmb-20240630xex10d2001.jpg | GRAPHIC | 939
9 | GRAPHIC | tmb-20240630xex10d2002.jpg | GRAPHIC | 831
| Complete submission text file | 0001070081-24-000017.txt |  | 15101526

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EX-101.SCH | tmb-20240630.xsd | EX-101.SCH | 88224
11 | EX-101.CAL | tmb-20240630_cal.xml | EX-101.CAL | 80898
12 | EX-101.DEF | tmb-20240630_def.xml | EX-101.DEF | 433262
13 | EX-101.LAB | tmb-20240630_lab.xml | EX-101.LAB | 824006
14 | EX-101.PRE | tmb-20240630_pre.xml | EX-101.PRE | 660699
102 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20240630x10q_htm.xml | XML | 3141763

Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 241189064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)